Conclusions: Large, well-designed trials (ideally with hard clinical outcome measures) that consider facall the complexities involved in CIN and its prevention are needed before the clinical community has the evidence-based direction required for optimized patient care.
PMID: 19557710 [PubMed - in process] (Source: Journal of Nephrology)